Jones Financial Companies
ONCY

Jones Financial Companies’s Oncolytics Biotech ONCY Stock Holding History

Jones Financial Companies’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.59K Buy
4,278
+2,225
+108% +$2.21K ﹤0.01% 3965
2025
Q4 		$1.79K Hold
2,053
– – ﹤0.01% 3851
2025
Q3 		$2.65K Hold
2,053
– – ﹤0.01% 3599
2025
Q2 		$1.54K Buy
+2,053
New +$1.09K ﹤0.01% 3547

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jones Financial Companies's ONCY Position: Q1 2026 in Review

Jones Financial Companies increased its Oncolytics Biotech (ONCY) stake by 108% in Q1 2026, buying an estimated $2.21K and bringing the position to 4,278 shares worth $3.59K. The position accounts for ﹤0.01% of the portfolio, ranked #3965.

Jones Financial Companies first reported a position in ONCY in Q2 2025 and has held it in 4 quarters since. 59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.

  • Jones Financial Companies held 4,278 shares of Oncolytics Biotech worth $3.59K as of Q1 2026.
  • Jones Financial Companies bought 2,225 Oncolytics Biotech shares in Q1 2026, an estimated $2.21K.
  • Oncolytics Biotech made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #3965 holding.
  • Jones Financial Companies first reported a position in Oncolytics Biotech in Q2 2025 and has held it in 4 quarters since.
  • 59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.